Health Secretary Tom Price’s Investment Portfolio Has Directly Benefited From His Pharma Agenda
Before he was named Trump’s health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed